Obstetric conditions associated with the need for blood transfusion may lead to morbidity and mortality if not managed correctly. The increasingly important issues in blood transfusion are adverse events associated with transfusion, including potential infection and potential transmission of prions, rising costs and the possible future problems of availability. Unfortunately, information from randomised controlled trials to inform best practice is largely unavailable in the discipline of blood transfusion.
This guideline provides advice about appropriate use of blood products. It is envisaged that this guideline will be incorporated into a protocol for each unit to disseminate locally.